image
Technology - Software - Infrastructure - NASDAQ - IL
$ 15.45
1.64 %
$ 3.7 B
Market Cap
-16.79
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one CLBT stock under the worst case scenario is HIDDEN Compared to the current market price of 15.4 USD, Cellebrite DI Ltd. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one CLBT stock under the base case scenario is HIDDEN Compared to the current market price of 15.4 USD, Cellebrite DI Ltd. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one CLBT stock under the best case scenario is HIDDEN Compared to the current market price of 15.4 USD, Cellebrite DI Ltd. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLBT

image
$26.0$26.0$24.0$24.0$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.020252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25
FINANCIALS
401 M REVENUE
23.41%
56.9 M OPERATING INCOME
71.21%
-283 M NET INCOME
-248.96%
132 M OPERATING CASH FLOW
29.51%
-149 M INVESTING CASH FLOW
-563.15%
20.7 M FINANCING CASH FLOW
-5.12%
108 M REVENUE
-1.38%
12.3 M OPERATING INCOME
-21.99%
17.4 M NET INCOME
-9.70%
20.9 M OPERATING CASH FLOW
-68.35%
-127 M INVESTING CASH FLOW
-693.18%
3.62 M FINANCING CASH FLOW
-46.21%
Balance Sheet Cellebrite DI Ltd.
image
Current Assets 568 M
Cash & Short-Term Investments 447 M
Receivables 82.4 M
Other Current Assets 38 M
Non-Current Assets 123 M
Long-Term Investments 36.6 M
PP&E 27.6 M
Other Non-Current Assets 58.8 M
64.76 %11.93 %5.50 %5.30 %4.00 %8.51 %Total Assets$690.6m
Current Liabilities 296 M
Accounts Payable 11.1 M
Short-Term Debt 0
Other Current Liabilities 284 M
Non-Current Liabilities 65 M
Long-Term Debt 6.84 M
Other Non-Current Liabilities 58.2 M
3.07 %78.89 %16.14 %Total Liabilities$360.5m
EFFICIENCY
Earnings Waterfall Cellebrite DI Ltd.
image
Revenue 401 M
Cost Of Revenue 62.6 M
Gross Profit 339 M
Operating Expenses 282 M
Operating Income 56.9 M
Other Expenses 340 M
Net Income -283 M
500m500m400m400m300m300m200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)401m(63m)339m(282m)57m(340m)(283m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
84.40% GROSS MARGIN
84.40%
14.18% OPERATING MARGIN
14.18%
-70.54% NET MARGIN
-70.54%
-84.22% ROE
-84.22%
-40.98% ROA
-40.98%
14.77% ROIC
14.77%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cellebrite DI Ltd.
image
140m140m120m120m100m100m80m80m60m60m40m40m20m20m00202020202021202120222022202320232024202420252025
Net Income -283 M
Depreciation & Amortization 10.6 M
Capital Expenditures -10.6 M
Stock-Based Compensation 30.6 M
Change in Working Capital 42 M
Others 363 M
Free Cash Flow 122 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cellebrite DI Ltd.
image
Wall Street analysts predict an average 1-year price target for CLBT of $19.2 , with forecasts ranging from a low of $17 to a high of $23 .
CLBT Lowest Price Target Wall Street Target
17 USD 10.03%
CLBT Average Price Target Wall Street Target
19.2 USD 24.60%
CLBT Highest Price Target Wall Street Target
23 USD 48.87%
Price
Max Price Target
Min Price Target
Average Price Target
262624242222202018181616141412121010Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Cellebrite DI Ltd.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Cellebrite to Acquire Corellium Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing globenewswire.com - 1 month ago
Cellebrite Announces Participation in Upcoming Investor Conferences TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company plans to participate in the following investor conferences in May and June: Date: May 28, 2025 Conference: Craig-Hallum Institutional Investor Conference Format: 1x1 Meetings Only Cellebrite executives: Dana Gerner, chief financial officer Andrew Kramer, vice president, investor relations Date: May 29, 2025 Conference: TD Cowen 52nd Annual Technology, Media & Telecom Conference Presentation Time: 11:25 a.m. globenewswire.com - 1 month ago
Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings Lifecore, Burford, KKR, PAR, and Cellebrite are well-positioned despite trade policy and tariff headwinds, each with unique catalysts for growth. KKR stands out for its asset growth, brand strength, and resilience, benefiting from the migration to private assets and high-net-worth channels. PAR's high-margin software, resilient QSR customer base, and strong growth prospects outweigh tariff risks and support a bullish outlook. seekingalpha.com - 1 month ago
Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Tomer Zilberman - Bank of America Jeff Rhee - Craig-Hallum Mike Cikos - Needham Jonathan Ho - William Blair Shaul Eyal - TD Cowen Eric Martinuzzi - Lake Street Operator Welcome to the Cellebrite First Quarter 2025 Financial Results Conference Call. seekingalpha.com - 1 month ago
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. zacks.com - 1 month ago
Cellebrite Announces First-Quarter 2025 Results First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue globenewswire.com - 1 month ago
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform globenewswire.com - 2 months ago
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025 TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. globenewswire.com - 2 months ago
10 Winners Awarded “Justies” at Cellebrite's First-Ever Digital Justice Awards The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees globenewswire.com - 3 months ago
Cellebrite Files its 2024 Annual Report on Form 20-F TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”). globenewswire.com - 3 months ago
SMGZY or CLBT: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 4 months ago
After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT) Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. zacks.com - 4 months ago
8. Profile Summary

Cellebrite DI Ltd. CLBT

image
COUNTRY IL
INDUSTRY Software - Infrastructure
MARKET CAP $ 3.7 B
Dividend Yield 0.00%
Description Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Contact 94 Shlomo Shmelzer Road, Petah Tikva, 4970602 https://www.cellebrite.com
IPO Date Nov. 6, 2020
Employees 1167
Officers Andrew Kramer Vice President of Investor Relations Ms. Sigalit Shavit Chief Information Officer Mr. Marcus Jewell Global Chief Revenue Officer Ms. Ayala Berler Shapira General Counsel & Chief Compliance Officer Mr. Ronnen Armon Chief Products & Technologies Officer Mr. Thomas E. Hogan Chief Executive Officer & Director Ms. Dana Gerner Chief Financial Officer Mr. David Nicholas Gee Chief Marketing Officer Ms. Zohar Tadmor-Eilat Chief People Officer Mr. Yossi Carmil Founder